EWTX Edgewise Therapeutics, Inc.
$44.40▲ +3.50%
Healthcare
Other
After hours
$46.04▲ +3.69%
Sep 11, 7:30 PM ET
Volume 1.31M
Avg Volume (10D) 945.1K
Key Metrics & Fundamentals
Market Cap
$4.82B
P/E Ratio
–
Div Yield
–%
52W Range
13.69 - 48.40
% vs 50 MA
1.22%
% vs 200 MA
28.83%
RSI-14
50.0
MACD Histogram
-0.1700
Beta (1Y vs SPY)
1.34
Free Cash Flow
-$42.50M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$61.35M
COGS
–
Operating Exp
$61.94M
Operating Income
-$61.94M
EBIT
-$61.94M
Pretax Income
-$57.33M
Net Income
-$57.33M
EPS (Diluted)
-0.53
Price & Volume History
Loading chart…
Recent News
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
PR Newswire · Sep 2, 2026 12:00 PM
Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026
PR Newswire · Aug 24, 2026 12:00 PM
Hypertrophic Cardiomyopathy Market Set for Transformation Over the Next Decade with the Emergence of Targeted Cardiac Therapies Beyond Conventional Beta-blockers, Calcium Channel Blockers, and Antiarrhythmic Agents | DelveInsight
PR Newswire · Aug 17, 2026 2:32 PM
Wedbush Adjusts Pt on Edgewise Therapeutics to $53 From $52, Maintains Outperform Rating
MT Newswires · Aug 7, 2026 10:08 AM
Edgewise Therapeutics Reports Second Quarter 2026 Financial Results
PR Newswire · Aug 6, 2026 12:00 PM
Edgewise Therapeutics (EWTX) Trades At A Rich P B, Is The Premium Justified?
Simply Wall St. · Jul 21, 2026 10:08 AM
Viking Therapeutics to Report Q2 Earnings: What's in Store for the Stock?
Zacks · Jul 17, 2026 2:42 PM
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
PR Newswire · Jul 13, 2026 12:30 PM
Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
PR Newswire · Jul 13, 2026 12:30 PM
Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says
MT Newswires · Jul 9, 2026 3:17 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See EWTX's money flow as a full page
Social Sentiment
No Reddit posts found for EWTX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.